touchIME

The 'Learner-to-Patient Impact Framework' (touchLPI) advances our holistic approach to delivering impactful education that has a positive impact on patient health.

In this episode, Dr William (Bill) Damsky discusses JAK inhibitors' journey from proof-of-concept to treating a wide range of skin conditions, their future impact on rare diseases and the debate around safety.

In this episode, we speak with Prof. John Mascarenhas, about the coalition's founding, operational mechanics and how their efforts have led to paradigm-shifting therapies in the field.

We caught up with two leading experts Prof. Barbara Yawn and Patient Advocate JoJo O’Neal to gain their perspectives on the importance of “the patient voice” in healthcare practices.

"We are excited to collaborate with COSTEM, aligned by our shared dedication to the oncology and hematology communities, with the goal of facilitating the exchange of knowledge and experiences to advance progress towards improved patient outcomes."

‘Closed-loop’ systems mark a significant advancement in managing type 1 diabetes. These systems which continuously monitor glucose levels and automatically deliver insulin through a pump, help many individuals with type 1 diabetes maintain optimal glucose levels with greater ease. In this episode, we explore the progress, challenges and impact of these innovative technologies with Endocrinology Clinical Pharmacy Specialist, Dr Diana Isaacs, and highlight their future potential.

touchONCOLOGY and touchRESPIRATORY support World Lung Cancer Day and aim to spread greater awareness about this common and fatal cancer.

touchONCOLOGY are excited to be partnering with the The Colorectal Cancer Alliance.

touchOPHTHALMOLOGY are very pleased to be partnering with the World Society of Paediatric Ophthalmology and Strabismus (WSPOS).